More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand Godha Read more
KSRPA writes to DCGI proposing amendments in D&C Act 1940 to safeguard registered pharmacists Read more
NPPA dismisses AstraZeneca’s plea and fixes retail price Dapagliflozin + Metformin formulation of Micro Labs Read more
India, South Africa call for waiver of IP, patents under certain TRIPS provisions for COVID-19 therapeutics Read more